'The Need for Speed: Gaining the right support to accelerate your small molecule candidate'
Kindly hosted by Arcinova
Friday 31 July, 10.00 - 11.00 BST
Kindly hosted by Arcinova
Friday 31 July, 10.00 - 11.00 BST
OBN Digital Event:
'The Need for Speed - Gaining the right support to accelerate your small molecule candidate'
About the Event
This digital event is kindly hosted by Arcinova and will feature an industry case study and panel discussion, addressing the benefits of using the services of a contract development and manufacturing organisation to support the journey of your small molecule candidate through to clinic as swiftly, effectively and economically as possible.
This session is designed to provide you with a range of useful advice of what to consider and be aware of when choosing and working with a partner. This will include factors such as: Location, speed, experience, technical expertise, capacity and agility.
After the panel discussion, speakers will be available to answer your questions and provide practical advice and support regarding your company growth, overcoming barriers and problem solving.
This digital event is kindly hosted by Arcinova and will feature an industry case study and panel discussion, addressing the benefits of using the services of a contract development and manufacturing organisation to support the journey of your small molecule candidate through to clinic as swiftly, effectively and economically as possible.
This session is designed to provide you with a range of useful advice of what to consider and be aware of when choosing and working with a partner. This will include factors such as: Location, speed, experience, technical expertise, capacity and agility.
After the panel discussion, speakers will be available to answer your questions and provide practical advice and support regarding your company growth, overcoming barriers and problem solving.
Format and panelists
The session will be moderated by Dr Nathalie Huther, Senior Director of Business Development, Europe at Arcinova, and the panelists will include:
- Dr Gareth Jenkins, CSO at Arcinova
- Professor Chris Frampton, CEO of Rbar3 - a Chemistry, Solid-form and Crystallographic Consultancy service to the pharmaceutical and fine chemical industry sectors
- Dr Stephen Brown Pharmaceutical Consultant and Advisor to a number of Biotech, CRO/CDMOs and technology companies involved in pharmaceutical product development.
The session will be moderated by Dr Nathalie Huther, Senior Director of Business Development, Europe at Arcinova, and the panelists will include:
- Dr Gareth Jenkins, CSO at Arcinova
- Professor Chris Frampton, CEO of Rbar3 - a Chemistry, Solid-form and Crystallographic Consultancy service to the pharmaceutical and fine chemical industry sectors
- Dr Stephen Brown Pharmaceutical Consultant and Advisor to a number of Biotech, CRO/CDMOs and technology companies involved in pharmaceutical product development.
How to book
Attendance at this event is complimentary please register to book your place.
Please note that this session will be live and recorded for follow-on viewing.
Attendance at this event is complimentary please register to book your place.
Please note that this session will be live and recorded for follow-on viewing.
About Arcinova
Arcinova are a multi-service Contract Development and Manufacturing Organisation who provide a wide range of services that support companies across the drug development pathway and includes expertise in drug substance sythesis and manufacturing scale up, drug product manufacture, bioanalytical services and radio labelling synthesis.
